Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

SHE/300937 stock hub

SHE/300937 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300937is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.7B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300937

In the news

Latest news · SHE/300937

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/En/a

P25 23.5P50 41.3P75 83.2

ROE-2.4

P25 -0.9P50 4.1P75 8.8

ROIC-13

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300937 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

CNY

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,170
Employees Change	56%
Employees Change Percent	5.03
Enterprise value	CNY 2.5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Last refreshed	2026-05-10
Market cap	CNY 2.7B
Price	CNY 27.85
Price currency	CNY
Rev Per Employee	3,786,587.57x
Sector	Healthcare
Sic	5912
Symbol	she/300937
Website	https://www.hezongyy.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.74%
EV Earnings	-129x
EV/EBIT	62.69x
EV/EBITDA	40.21x
EV/FCF	132.74x
EV/Sales	0.58x
FCF yield	0.72%
P/B ratio	3.32x
P/S ratio	0.6x
PE Ratio3 Y	91.16x
PE Ratio5 Y	179.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.92%
EBITDA Margin	1.41%
FCF margin	0.43%
Gross margin	10.19%
Gross Profit	CNY 451.3M
Gross Profit Growth	18.14%
Gross Profit Growth Q	-7.15%
Gross Profit Growth3 Y	14.87%
Gross Profit Growth5 Y	19%
Net Income	CNY -19.8M
Pretax Margin	0.09%
Profit Margin	-0.45%
Profit Per Employee	CNY -16,885
ROA	1.4
Roa5y	1.62
ROCE	4.96
ROE	-2.38
Roe5y	2.42
ROIC	-12.99
Roic5y	1.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	9.91%
Cagr3y	-2.89%
Cagr5y	-11.5%
Div CAGR3	-20.63%
FCF Growth Q	39.78%
OCF Growth Q	17.21%
Revenue Growth	1.35x
Revenue Growth Q	4.55x
Revenue Growth3 Y	3.92x
Revenue Growth5 Y	9.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 2.44
Assets	CNY 1.9B
Cash	CNY 445.2M
Current Assets	CNY 1.4B
Current Liabilities	CNY 904.1M
Debt	CNY 346.1M
Debt EBITDA	CNY 5.46
Debt Equity	CNY 0.43
Debt FCF	CNY 18.03
Equity	CNY 801.4M
Interest Coverage	712.2
Liabilities	CNY 1.1B
Long Term Assets	CNY 488.4M
Long Term Liabilities	CNY 185.5M
Net Cash	CNY 99.1M
Net Cash By Market Cap	CNY 3.72
Net Debt EBITDA	CNY -1.59
Net Debt Equity	CNY -0.12
Net Debt FCF	CNY -5.16
Tangible Book Value	CNY 763M
Tangible Book Value Per Share	CNY 9.06
WACC	4.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.46
Inventory Turnover	8.53
Net Working Capital	CNY 388.8M
Quick ratio	0.83
Working Capital	CNY 491.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.04%
Dividend Growth	-54.55%
Dividend Growth Years	0%
Dividend per share	CNY 0.1
Dividend Years	3
Dividend Yield	0.36%
Ex Div Date	2025-06-13
Last Dividend	CNY 0.1
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	9.9%
200-day SMA	31.05
3Y total return	-8.42%
50-day SMA	30.28
50-day SMA vs 200-day SMA	50under200
5Y total return	-45.69%
All Time High	150
All Time High Change	-81.43%
All Time High Date	2021-01-29
All Time Low	17.83
All Time Low Change	56.2%
All Time Low Date	2024-02-06
ATR	1.02
Beta	0.19
Beta1y	0.38
Beta2y	0.37
Ch YTD	-18.3
High	27.96
High52	44.38
High52 Date	2026-01-13
High52ch	-37.25%
Low	27.4
Low52	24.93
Low52 Date	2025-05-15
Low52ch	11.71%
Ma50ch	-8.03%
Price vs 200-day SMA	-10.31%
RSI	40.68
RSI Monthly	46.22
RSI Weekly	40.76
Sharpe ratio	0.42x
Sortino ratio	0.79
Total Return	0.32%
Tr YTD	-18.3
Tr1m	-9.61%
Tr1w	1.16%
Tr3m	-17.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 40.6M
Operating Income Growth	5.38
Operating Income Growth Q	9.34
Operating Income Growth3 Y	-8.73
Operating Income Growth5 Y	-6.68
Operating margin	0.92

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	42,388,482%
Net Borrowing	-43,789,692
Shares Insiders	47.54%
Shares Institutions	2.95%
Shares Out	95,666,682
Shares Qo Q	18.18%
Shares Yo Y	0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 19.2M
Average Volume	3,033,000.4x
Bv Per Share	9.71
CAPEX	CNY -8.3M
Ch1m	-9.61
Ch1w	1.16
Ch1y	9.52
Ch3m	-17.26
Ch3y	-10.22
Ch5y	-46.93
Ch6m	0.07
Change	1.05%
Change From Open	0.69
Close	27.56
Days Gap	0.36
Depreciation Amortization	21,297,410
Dollar Volume	62,683,805.3
Earnings Date	2026-04-29
EBIT	CNY 40.6M
EBITDA	CNY 62.5M
EPS	CNY -0.21
F Score	4
FCF	CNY 19.2M
FCF EV Yield	0.75x
FCF Per Share	CNY 0.2
Financing CF	43,313,392
Fiscal Year End	December
Founded	2,007
Goodwill	13,710,670
Income Tax	CNY 23.6M
Investing CF	-117,042,964
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2025-12-31
Ma150	31.56
Ma150ch	-11.74%
Ma20	29.13
Ma20ch	-4.39%
Net CF	-46,193,632
Next Earnings Date	2026-08-25
Open	27.66
P FCF Ratio	138.8
P OCF Ratio	96.72
Payment Date	2025-06-13
Position In Range	80.36
Ppne	143,749,398
Price Date	2026-05-08
Price EBITDA	CNY 42.65
Ptbv Ratio	3.49
Relative Volume	0.74x
Revenue	4,430,307,453x
Tax By Revenue	0.53x
Tax Rate	574.32%
Tr6m	0.07%
Volume	2,250,765

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300937 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$0.10 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.3%

Next ex-dividend date: 2025-06-13

Performance

SHE/300937 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300937?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.0%

Share of float held by funds and institutions

Insider ownership

+47.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

SHE/300937 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.7

Neutral momentum band

Price vs 200-day MA

-10.3%

50/200-day relationship not available

Beta (5Y)

0.19

Less volatile than the market

Sharpe ratio

0.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300937

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300937 stock rating?

she/300937 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300937 analysis?

The full report lives at /stocks/she/300937/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300937?

The latest report frames she/300937 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300937 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.